vs
PROSPERITY BANCSHARES INC（PB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
PROSPERITY BANCSHARES INC的季度营收约是REPLIGEN CORP的1.9倍（$367.6M vs $197.9M），PROSPERITY BANCSHARES INC净利率更高（31.6% vs 6.7%，领先24.9%），过去两年PROSPERITY BANCSHARES INC的营收复合增速更高（19.2% vs 14.4%）
Prosperity Bancshares Inc.是总部位于美国得克萨斯州休斯顿的银行控股公司，业务覆盖得克萨斯州及俄克拉荷马州中部。截至2019年12月31日，公司共运营285家分支机构，广泛分布在休斯顿、达拉斯-沃斯堡都会区及得州南部、东部、中部、西部等区域。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PB vs RGEN — 直观对比
营收规模更大
PB
是对方的1.9倍
$197.9M
净利率更高
PB
高出24.9%
6.7%
两年增速更快
PB
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $367.6M | $197.9M |
| 净利润 | $116.3M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 31.6% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | -10.7% | 143.9% |
| 每股收益（稀释后） | $1.16 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBRGEN
| Q1 26 | $367.6M | — | ||
| Q4 25 | $275.0M | $197.9M | ||
| Q3 25 | $273.4M | $188.8M | ||
| Q2 25 | $267.7M | $182.4M | ||
| Q1 25 | $265.4M | $169.2M | ||
| Q4 24 | $267.8M | $174.1M | ||
| Q3 24 | $261.7M | $154.9M | ||
| Q2 24 | $258.8M | $154.1M |
净利润PBRGEN
| Q1 26 | $116.3M | — | ||
| Q4 25 | $139.9M | $13.3M | ||
| Q3 25 | $137.6M | $14.9M | ||
| Q2 25 | $135.2M | $14.9M | ||
| Q1 25 | $130.2M | $5.8M | ||
| Q4 24 | $130.1M | $-30.3M | ||
| Q3 24 | $127.3M | $-654.0K | ||
| Q2 24 | $111.6M | $3.3M |
毛利率PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 65.1% | 9.0% | ||
| Q3 25 | 64.4% | 8.9% | ||
| Q2 25 | 64.3% | 7.6% | ||
| Q1 25 | 62.7% | 3.9% | ||
| Q4 24 | 62.0% | -17.7% | ||
| Q3 24 | 62.1% | -5.1% | ||
| Q2 24 | 55.2% | 1.0% |
净利率PBRGEN
| Q1 26 | 31.6% | — | ||
| Q4 25 | 50.9% | 6.7% | ||
| Q3 25 | 50.3% | 7.9% | ||
| Q2 25 | 50.5% | 8.2% | ||
| Q1 25 | 49.1% | 3.4% | ||
| Q4 24 | 48.6% | -17.4% | ||
| Q3 24 | 48.6% | -0.4% | ||
| Q2 24 | 43.1% | 2.2% |
每股收益（稀释后）PBRGEN
| Q1 26 | $1.16 | — | ||
| Q4 25 | $1.48 | $0.24 | ||
| Q3 25 | $1.45 | $0.26 | ||
| Q2 25 | $1.42 | $0.26 | ||
| Q1 25 | $1.37 | $0.10 | ||
| Q4 24 | $1.36 | $-0.55 | ||
| Q3 24 | $1.34 | $-0.01 | ||
| Q2 24 | $1.17 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $8.2B | $2.1B |
| 总资产 | $43.6B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益PBRGEN
| Q1 26 | $8.2B | — | ||
| Q4 25 | $7.6B | $2.1B | ||
| Q3 25 | $7.7B | $2.1B | ||
| Q2 25 | $7.6B | $2.1B | ||
| Q1 25 | $7.5B | $2.0B | ||
| Q4 24 | $7.4B | $2.0B | ||
| Q3 24 | $7.4B | $2.0B | ||
| Q2 24 | $7.3B | $2.0B |
总资产PBRGEN
| Q1 26 | $43.6B | — | ||
| Q4 25 | $38.5B | $2.9B | ||
| Q3 25 | $38.3B | $2.9B | ||
| Q2 25 | $38.4B | $2.9B | ||
| Q1 25 | $38.8B | $2.9B | ||
| Q4 24 | $39.6B | $2.8B | ||
| Q3 24 | $40.1B | $2.8B | ||
| Q2 24 | $39.8B | $2.9B |
负债/权益比PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $78.3M | $25.7M | ||
| Q3 25 | $194.8M | $48.1M | ||
| Q2 25 | $98.2M | $28.6M | ||
| Q1 25 | $178.2M | $15.0M | ||
| Q4 24 | $-205.8M | $39.2M | ||
| Q3 24 | $274.6M | $49.3M | ||
| Q2 24 | $216.5M | $42.2M |
自由现金流PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $68.5M | $17.6M | ||
| Q3 25 | $185.7M | $43.4M | ||
| Q2 25 | $91.8M | $21.5M | ||
| Q1 25 | $171.1M | $11.4M | ||
| Q4 24 | $-210.7M | $33.6M | ||
| Q3 24 | $270.2M | $42.3M | ||
| Q2 24 | $211.8M | $37.4M |
自由现金流率PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 24.9% | 8.9% | ||
| Q3 25 | 67.9% | 23.0% | ||
| Q2 25 | 34.3% | 11.8% | ||
| Q1 25 | 64.5% | 6.8% | ||
| Q4 24 | -78.7% | 19.3% | ||
| Q3 24 | 103.3% | 27.3% | ||
| Q2 24 | 81.8% | 24.3% |
资本支出强度PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 4.1% | ||
| Q3 25 | 3.3% | 2.5% | ||
| Q2 25 | 2.4% | 3.9% | ||
| Q1 25 | 2.7% | 2.1% | ||
| Q4 24 | 1.8% | 3.2% | ||
| Q3 24 | 1.7% | 4.5% | ||
| Q2 24 | 1.8% | 3.1% |
现金转化率PBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.56× | 1.93× | ||
| Q3 25 | 1.42× | 3.23× | ||
| Q2 25 | 0.73× | 1.92× | ||
| Q1 25 | 1.37× | 2.57× | ||
| Q4 24 | -1.58× | — | ||
| Q3 24 | 2.16× | — | ||
| Q2 24 | 1.94× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
RGEN
暂无分部数据
